R2G’s team stands with Ukraine
At R2G, we would like to express our support to all Ukrainian people and all the people who are suffering from the Russian invasion. Our team is for peace! Below we have collected a list of charities and initiatives that one can support to help. The below list will be updated regularly. Ukrainian Organizations Vostok Learn more...
Taking digital healthcare to the streets. Interview with Dr. Nikos Green, Senior Venture Architect & PO Neuroscience, RoX Health
To drive innovation and address unmet market needs many established healthcare companies form commercial partnerships with startups. Incorporating novel solutions and jointly running the digital health agenda is still based on trial-and-error process for many. Only every fourth partnership is considered to be successful. Is there a better way to drive open innovation? In a Learn more...
How to get your digital health app reimbursed in Europe? Start with Germany, Belgium and France.
Getting your digital health app prescribed by an HCP is something most digital health app vendors want. Three countries in Europe with more than 149 million public health insured citizens make it possible. See how it works in Germany, Belgium and France. An EU wide initiative to allow HCPs to prescribe digital health apps would Learn more...
The rise of Digital health ecosystems. It just takes 3 years to build one.
In the last 3-5 years there has been a rapid expansion of ecosystems consisting of digital health applications. Health insurance companies or insure-techs sometimes include up to 100 solutions from third-party providers in a wide variety of digital health segments. Ecosystem providers should now concentrate on improving their value proposition in order to be successful. Learn more...
Where is the money in digital health? The roadmap to digital health app reimbursement in Europe
Reimbursement opportunities for digital health applications and services will improve significantly over the next few years in Europe. An EU go-to-market plan for a digital health app must factor in the four different implementation stages of standardized reimbursement processes within the European countries to avoid ineffective resource allocation or just to be too early or Learn more...
What are the high-value segments in the digital decentralized clinical trial (DDCT) solution market?
The Digital Decentralized Clinical Trial solution (DDCT) market is one of the biggest digital health market segments in NA and Europe, with significant growth and business opportunities in the next years. Solution providers should wisely choose out of six market segments within this market to benefit the most from the market growth. The Covid Learn more...
dermanostic’s success path in Europe. Interview with CEO Dr. med. Martin
According to the World Health Organization, skin /dermatological diseases affect almost 900 million people globally at all times. The impact of skin conditions on quality of life, well-being, and mental health of people, along with the fact that the visible skin change could be an indication of more severe medical illnesses beneath, present an enormous Learn more...
R2G launches a new global annual survey: Global Digital Health Business Outlook – 2022
R2G launches a new Global Annual Digital Health Business Survey – 2022 to assess the digital health industry outlook in 2022. The survey is conducted by R2G on an on-going basis annually which focuses on gathering opinions from digital health decision makers on how the digital health industry will evolve in the coming year. The Learn more...
How Top Doctors wants to become a world leader in Telehealth specialist services. Interview with Alberto Porciani, Founder and CEO at Top Doctors.
The pandemic has created a need for virtual medical care and significantly transformed the acceptance of remote telehealth services among HCPs, patients, and regulators. In 2020, we witnessed an outburst of telehealth and e-consultation sessions, especially in primary care. Health tech innovators and healthcare stakeholders saw a major business opportunity and investors made serious moves Learn more...